​Our Founding Vision
​​Lumivascular Inc. was founded by a team of highly experienced professionals with a proven track record in developing and commercializing breakthrough technologies for the minimally invasive treatment of both peripheral and cardiovascular disease.
Collectively, the founders have driven innovations that have generated over $500 million in cumulative product revenue, treated over 200,000 patients worldwide, and created more than $1 billion in enterprise value across multiple MedTech companies.
Their deep expertise and shared vision continue to guide Lumivascular’s mission to redefine how physicians see and treat vascular disease and to improvise patient outcomes.
Founding Members
Himanshu Patel
Chief Executive Officer (CEO)
​​Himanshu Patel founded Avinger and served as Chief Technology Officer from 2007 to 2025, where he led the development of image-guided catheters for treating peripheral vascular disease (PAD). With over 35 years of experience in medical device design—primarily for arterial disease—he has contributed to more than 200 patents, and his ideas have generated over $1 billion in shareholder value. ​​ Prior Experience: FoxHollow Technologies Led R&D efforts where he conceptualized and developed the Silverhawk line of catheters. These products generated over $180 million in annual revenue, and the company was acquired for $740 million. Silverhawk products remain among the leading tools at Medtronic for the treatment of PAD. EndoTex Interventional Systems Made key contributions toward the company’s success, which led to its acquisition by Boston Scientific for $100 million. General Surgical Led manufacturing efforts to facilitate rapid growth in the production of endoscopic devices.
Ajoy Khandheria
President & Co-Founder
​​Ajoy Khandheria holds an engineering degree from India and an MBA from the University of California, Berkeley. He brings over 15 years of leadership experience in the IT and telecom sectors, including senior marketing and sales roles at Harris Corporation and Italcable (Italy's national telecom provider). Since 2008, Ajoy has been a serial entrepreneur and early-stage investor, backing more than 15 startups across healthcare and technology. He has founded multiple healthcare ventures in the U.S. and India, with a focus on scalable service and device-based models. Ajoy also founded Gramin Healthcare, a social enterprise delivering primary care in rural India. The organization operates a network of clinics that provide free medical consultations to over 150,000 patients annually, creating measurable impact on scale.
Our Team and Collaboration
We are a team of innovators, clinicians, and visionaries committed to shaping the future of vascular interventions. Together with our partners, we are charting a new course for how disease is treated, how patients recover, and how cardiologists practice. As a result, we together are creating a future where clarity replaces guesswork, where safety is never compromised and where the invisible is finally brought to light.
Thomas Lawson, PhD
Regulatory Affair
Dr. Lawson, is Lumivascular’s Regulatory Affairs Consultant and brings extensive experience from his previous role as Vice President of Clinical & Regulatory Affairs at Avinger. Before joining Avinger, he spent 25 years leading preclinical, clinical, and regulatory programs for eight start-up medical device companies, overseeing more than 80 studies across 13 countries. He holds a Ph.D. from the University of California, Berkeley.
Grace Li
Quality Assurance
Satyam Gupta, PhD
Business Development Consultant
Dr. Gupta, is Lumivascular’s Business Development Consultant for India, bringing over 16 years of expertise in MedTech strategy, market expansion, and clinical-commercial partnerships. He spearheads Lumivascular’s growth initiatives, building strong clinician engagement and scalable go-to-market pathways. Dr. Gupta holds a PhD in Business Management, an MBA in Marketing, and a Bachelor’s degree in Mathematics.
Krishna Deepak
Healthcare Strategy & Operations Consultant
Mr. Krishna Deepak is a healthcare founder and operator with extensive experience building and scaling businesses across the healthcare ecosystem. A former Private Equity Operating Partner and BCG Principal, he has advised industry leaders including the FDA on strategy, clinical trials, and quality systems. At Lumivascular, he guides the leadership team on clinical-trial strategy, quality, and commercialization.